Prasanth Jayaraj, Prasad Manya, Mahapatra Soumya Jagannath, Krishna Asuri, Prakash Om, Garg Pramod Kumar, Bansal Virinder Kumar
Department of Surgical Disciplines, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Clinical Research Epidemiology, Department of Clinical Research, Biostatistics and Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
World J Surg. 2022 Jun;46(6):1359-1375. doi: 10.1007/s00268-022-06501-4. Epub 2022 Mar 19.
Recommendations regarding the timing of cholecystectomy for acute biliary pancreatitis (ABP) require a systematic summary of current evidence to guide clinical practice. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing early cholecystectomy (EC) versus delayed cholecystectomy (DC) in patients with ABP.
We searched databases Medline, Embase, SCOPUS, Web of Science and Cochrane CENTRAL for randomized controlled trials addressing this question. Pairs of reviewers abstracted data and assessed the risk of bias in included studies. A random-effects meta-analysis was done to study the effect of the timing of cholecystectomy on outcomes of interest in patients with ABP. GRADE methodology was used to rate the quality in the body of evidence for each outcome as high, moderate, low, or very low.
11 randomized trials (1176 participants) were included. High-quality evidence from seven RCTs (867 participants) showed a statistically significant reduction in the risk for recurrent biliary events in favour of early cholecystectomy (RR 0.10, 95% CI 0.05 to 0.19, I = 0%). High-quality evidence from five trials was in favour of early cholecystectomy with a significant reduction in the risk 7of recurrent pancreatitis (RAP) in comparison to delayed cholecystectomy (RR 0.21, 95% CI 0.09 to 0.51, I = 0%).
This review showed that EC has definite advantages over DC in terms of reducing recurrent pancreaticobiliary events and LOS following mild ABP. However, more RCTs are required to study the role of EC in patients with moderately-severe and severe ABP. Trial Registration Protocol registered on Prospero (CRD42020192823).
关于急性胆源性胰腺炎(ABP)胆囊切除术时机的建议需要对当前证据进行系统总结,以指导临床实践。我们对比较ABP患者早期胆囊切除术(EC)与延迟胆囊切除术(DC)的随机对照试验(RCT)进行了系统评价和荟萃分析。
我们检索了Medline、Embase、SCOPUS、Web of Science和Cochrane CENTRAL数据库,以查找针对该问题的随机对照试验。由两名评价员提取数据并评估纳入研究的偏倚风险。进行随机效应荟萃分析,以研究胆囊切除术时机对ABP患者感兴趣结局的影响。采用GRADE方法将每个结局的证据质量评为高、中、低或极低。
纳入11项随机试验(1176名参与者)。来自7项RCT(867名参与者)的高质量证据显示,早期胆囊切除术可使复发性胆系事件风险显著降低(RR 0.10,95%CI 0.05至0.19,I=0%)。五项试验的高质量证据支持早期胆囊切除术,与延迟胆囊切除术相比,复发性胰腺炎(RAP)风险显著降低(RR 0.21,95%CI 0.09至0.51,I=0%)。
本评价表明,在减少轻度ABP后的复发性胰胆事件和住院时间方面,EC比DC具有明显优势。然而,需要更多的RCT来研究EC在中重度和重度ABP患者中的作用。试验注册方案已在Prospero上注册(CRD42020192823)。